Table 3.
Fourteen miRNAs dysregulated in experimental animal models of AMD, and in AMD patient tissue
miRNA | Experimental AMD models | Patient | |||||||
---|---|---|---|---|---|---|---|---|---|
Strand | FCd | Tissue | Manipulationc | Source | Strand | FCd | Tissue | Source | |
miR-106a | mmu-miR-106aa | + | Mouse retina | OIR | [90] | hsa-miR-106a-5p | 3.45 | Plasma | [103] |
miR-106b | hsa-miR-106b-5p | 0.11 | ARPE-19 cells | Oxidative stress | [82] | hsa-miR-106b-5p | −1.5 | Plasma | [57] |
hsa-miR-106b-5p | −0.23 | VH | [57] | ||||||
miR-125b | hsa-miR-125b-5p | + | ARPE-19 cells | Oxidative stress | [82] | hsa-miR-125ba | + | Retina | [56] |
mmu-miR-125b-5p | 2.07 | Mouse retina | OIR | [75] | |||||
miR-146a | hsa-miR-146aa | + | Human RPE | Chronic oxidative stress | [73] | hsa-miR-146a-5p | 2.5 | Plasma | [57] |
mmu-miR-146a-5p | 3.02 | Mouse retina | Selective Müller cell ablation | [74] | hsa-miR-146aa | 2.1 | Retina | [56] | |
hsa-miR-146aa | + | Human RPE | treatment with pro-inf cytokines | [71] | hsa-miR-146a-5p | 3.02 | VH | [57] | |
mmu-miR-146a-5p | 0.3 | Mouse retina | OIR | [75] | |||||
miR-155 | mmu-miR-155-5p | 55.92 | Rat retinas | Light induced retinal degeneration | [99] | hsa-miR-155a | + | Retina, macula | [56] |
mmu-miR-155-5p | 5.87 | Mouse retina | OIR | [75] | |||||
hsa-miR-155a | + | Human RPE | Treatment with pro-inf cytokines | [113] | |||||
miR-17 | hsa-miR-17-5p | + | ARPE-19 cells | Oxidative stress | [82] | hsa-miR-17-5p | 2.77 | Plasma | [103] |
mmu-miR-17-5p | 3.16 | Mouse retina | OIR | [75] | |||||
miR-184 | mmu-miR-184a | – | Mouse retina | OIR | [90] | hsa-miR-184a | – | RPE culture | [89] |
miR-21 | hsa-miR-21a | – | Human RPE | Chronic oxidative stress | [73] | hsa-miR-21-5p | −3.09 | Plasma | [103] |
hsa-miR-21-5p | + | ARPE-19 cells | Oxidative stress | [82] | |||||
miR-223 | hsa-miR-223-3p | + | ARPE-19 cells | Oxidative stress | [82] | hsa-miR-223-3p | 1.65 | Plasma | [103] |
mmu-miR-223-3p | 0.32 | Mouse retina | OIR | [75] | |||||
miR-23a | hsa-miR-23a-3p | + | ARPE-19 cells | Oxidative stress | [82] | hsa-miR-23aa | – | Macular RPE | [104] |
mmu-miR-23a-3p | 0.16 | Mouse retina | OIR | [75] | |||||
miR-29a | hsa-miR-29aa | + | Human RPE | Chronic oxidative stress | [73] | hsa-miR-29a-3p | o.p.b | Plasma | [103] |
hsa-miR-29b-3p | 0.05 | ARPE-19 cells | Oxidative stress | [82] | |||||
miR-342-3p | mmu-miR-342-3p | 0.47 | Mouse retina | OIR | [75] | hsa-miR-342-3p | o.p. b | Plasma | [103] |
miR-374a | hsa-miR-374a-5p | 0.1 | ARPE-19 cells | Oxidative stress | [82] | hsa-miR-374a-5p | −12.92 | Plasma | [103] |
miR-424 | mmu-miR-424a | + | Mouse retina | OIR | [90] | hsa-miR-424-5p | −0.338 | Plasma | [51] |
hsa-miR-424-5p | 3.97; 3.28 | Serum | [52] |
FC fold change, AMD age-related macular degeneration, miRNA micro RNA, GA AMD graphic atrophy AMD, RPE retinal pigment epithelium, OIR oxygen-induced retinopathy, VH vitreous humor, pro-inf pro-inflammatory, ARPE-19 adult retinal pigment epithelium cell line
aMature miRNA strand unknown/not mentioned
bo.p.: miRNA was only expressed in the patient group
cOxidative stress was induced using H2O2 [82] or Paraquat [73]
dA “+” indicates miRNA upregulated/higher levels and “−” indicates miRNA downregulated/lower levels